In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation
Case Number:
2:17-md-02785
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Law Offices of Ursula Taylor
- Groom Law Group
- Foley & Lardner
- Matthew G. Miller PC
- Spencer Fane
- Foulston Siefkin
- Sharp Law LLP
- Parker Waichman
- Holland & Knight
- Siegfried & Jensen
- Spragens Law
- Steven Williams Law
- Barnow & Associates
- Goldman Scarlato
- Robbins Geller
- Squitieri & Fearon
- Wilson Sonsini
- Kramer Levin
- King & Spalding
- Saiber LLC
- Weil Gotshal
- McCune Wright
- Blood Hurst
- Berkowitz Oliver
- Baron & Budd
- Barton & Burrows
- Pallas Partners
- Kaufman & Canoles
- Mehri & Skalet
- Beasley Allen
- Williams & Connolly
- Robbins Russell
- Pritzker Levine
- Gibbs Law Group
- DiCello Levitt
- Gibbons PC
- Lockridge Grindal
- Yarmuth LLP
- Lanier Law Firm
- Keller Rohrback
- Fredrikson & Byron
- Hinkle Law Firm
- Robins Kaplan
- Carella Byrne
- Lathrop GPM
- Burns Charest
- Marion's Inn
- Berman Tabacco
- Sidley Austin
- Ali & Lockwood
- Strategic Health Law
- Boies Schiller
- Dollar Burns
- Gibson Dunn
- DLA Piper
- Perkins Coie
- Butler Prather
- Hogan Lovells
- Clark Hill
- Hagens Berman
- Reed Smith
- Levi & Korsinsky
- Gustafson Gluek
- Goodwin Procter
- Bradford & Wilson
- Horn Aylward
- Joseph Saveri Law Firm
- Bush Seyferth
- Wagstaff & Cartmell
- Shook Hardy
- Lowey Dannenberg
- Lightfoot Franklin
- GM Law PC
- Latham & Watkins
- Mayer Brown
- White & Case
- Willkie Farr
Companies
- Amerigroup Corp.
- Change Healthcare Inc.
- MedImpact Healthcare Systems Inc.
- CVS Health Corp.
- Express Scripts Holding Co.
- Aetna Inc.
- Blue Cross Blue Shield Association
- Coventry Health Care Inc.
- Meridian Medical Technologies Inc.
- The Segal Co. Inc.
- Optum Inc.
- Pfizer Inc.
- Viatris Inc.
- Humana Inc.
- King Pharmaceuticals Inc.
- OptumRx Inc.
- Sanofi
- Centene Corp.
- UnitedHealth Group Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
August 20, 2018
Mylan, Pfizer Barely Put Dent In EpiPen Antitrust MDL
Mylan NV and Pfizer Inc. on Monday largely failed to scale down multidistrict litigation over sky-high prices for emergency allergy treatment EpiPen, as a Kansas federal judge mostly refused to throw out wide-ranging consumer claims of anti-competitive shenanigans.
-
June 12, 2018
Humana Ordered To Turn Over Docs In EpiPen Antitrust MDL
A Kansas federal judge on Monday ordered Humana Inc. to hand over within three weeks documents related to a multidistrict litigation accusing drugmaker Mylan NV of antitrust violations related to a surge in the price of its allergy treatment device, the EpiPen.
- ← Previous
- 1
- 2
- 3
- 4
- 5
- Next →